← back to search

Omar Massoud

University of Alabama at Birmingham · US
Area of research
Epidemiology · Hepatology
Research interest
Research interests include Medicine, Internal medicine, Cirrhosis, Hepatitis C, Hepatocellular carcinoma, and Retrospective cohort study.
h-index
citations
656
works
12
NIH funding
primary concept
email

Recent publications

Hepatocellular carcinoma surveillance: An evidence-based approach
World Journal of Gastroenterology 2019cited by 223position: middledoi
Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo
Clinical Gastroenterology and Hepatology 2018cited by 99position: middledoi
Resolution of ascites and hepatic encephalopathy and absence of variceal bleeding in decompensated hepatitis C virus cirrhosis patients
JGH Open 2018cited by 15position: lastdoi
Effect of Hepatitis C Treatment on Renal Function in Liver Transplant Patients
Journal of Clinical and Translational Hepatology 2018cited by 2position: lastdoi
Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
Clinics in Liver Disease 2017cited by 85position: firstdoi
Short article: Alcohol and substance use, race, and insurance status predict nontreatment for hepatitis C virus in the era of direct acting antivirals: a retrospective study in a large urban tertiary center
European Journal of Gastroenterology & Hepatology 2017cited by 26position: lastdoi
Hepatitis C virus testing for case identification in persons born during 1945‐1965: Results from three randomized controlled trials
Hepatology 2017cited by 23position: middledoi
Uptake of hepatitis C screening, characteristics of patients tested, and intervention costs in the BEST‐C study
Hepatology 2016cited by 24position: middledoi
Hepatitis C Virus Antibody Positivity and Predictors Among Previously Undiagnosed Adult Primary Care Outpatients: Cross-Sectional Analysis of a Multisite Retrospective Cohort Study
Clinical Infectious Diseases 2015cited by 34position: middledoi
Hepatitis C Virus Testing Perspectives Among Primary Care Physicians in Four Large Primary Care Settings
Health Promotion Practice 2014cited by 21position: middledoi
Randomized Study of Asunaprevir plus Pegylated Interferon-α and Ribavirin for Previously Untreated Genotype 1 Chronic Hepatitis C
Antiviral Therapy 2013cited by 46position: middledoi
Equivalent survival following liver transplantation in patients with non-alcoholic steatohepatitis compared with patients with other liver diseases
HPB 2012cited by 58position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

David B. Rein · National Opinion Research Center4 papers (2014–2017)Mohamed Shoreibah · University of Alabama at Birmingham4 papers (2017–2019)Kimberly Brown · University of Rochester Medical Center4 papers (2014–2017)Bryce D. Smith · Kent State University4 papers (2014–2017)Omar T. Sims · Cleveland Clinic3 papers (2017–2018)John Romano · University of Alabama at Birmingham3 papers (2017–2018)Krishna Venkata · University of Alabama at Birmingham3 papers (2017–2018)Vishnu Kommineni · University of Alabama at Birmingham3 papers (2017–2018) · 3 papers (2014–2017)Yuqi Guo · Zhengzhou University3 papers (2017–2018)Anthony Yartel · University of Connecticut3 papers (2015–2017)Joanne E. Brady · Guy's and St Thomas' NHS Foundation Trust2 papers (2016–2017)Michael B. Fallon · University of Arizona2 papers (2015–2018) · 2 papers (2016–2017)David R. Nerenz · Neurological Surgery2 papers (2016–2017)Alex D. Federman · San Francisco General Hospital2 papers (2016–2017)Paul Fitzmorris · University of Alabama at Birmingham2 papers (2017–2018)Brendan M. McGuire · University of Alabama at Birmingham2 papers (2012–2019)Dominique Larrey · University Hospital Frankfurt1 papers (2013–2013)Jean L. Chan · The University of Texas Southwestern Medical Center1 papers (2018–2018)